VIM and breast cancer: Consequently, MTF might reduce the invasive capacity of mesenchymal primary breast cancer cells by lowering SNAIL and Vimentin, which are also important factors involved in the structural changes of the cytoskeleton and thus in cell motility and invasiveness creating a phenotypic switch [55].